Clinical Efficacy Study Of "Removing Dampness And Clearing The Lung" On 60 Patients With COVID-19 Syndrome Of Damp-heat Inclusion Of Lung

This paper mainly includes two parts: clinical trial study and research progress of traditional Chinese and western medicineThe literature review includes two parts: the latest research progress of COVID-19 in Chinese and Western medicine.The first part,"Progress in Western Medicine Research",mainly summarizes the nomenclature and manifestation of COVID-19,epidemiology,pathology,pathogenesis,clinical diagnosis,and current treatment methods.The second part "the progress of TCM research",including TCM naming,etiology and pathogenesis,and TCM syndrome differentiation and treatment.Methods: A total of 60 patients with mild and common COVID-19 who were dialectically diagnosed as the syndrome of dampness-heat accumulation of lung in the hospital in Chengdu,Sichuan were collected.According to the random number table method,they were divided into "basic drugs + Chinese medicine group" and "basic drugs group"(the former group was referred to as the experimental group and the latter group as the control group).The basis of the control group only use regulations drug treatment,patients in basic medicine on "herb Piao Xia three decoction and fructus forsythiae powder",observe two groups before and after treatment of TCM syndrome integral,routine blood,c-reactive protein,liver and kidney function,immune index,D-dimer,blood coagulation function and will be coronavirus nasopharyngeal swabs turn time integral and chest CT changes.Statistical data in this study were analyzed by SPSS26.0 statistical software.Results:1.Comparison of TCM syndrome scores: primary symptoms(cough,sputum,sore throat,dry mouth): the scores of the test group decreased significantly,indicating better efficacy(P<0.05);secondary symptoms(fatigue,chest tightness,head and body drowsiness,muscle pain,nausea and vomiting,loose stools or sticky stool): the efficacy of the test group was similar to that of the control group.2.Laboratory results: there were significant differences in CRP,CD4+/CD8+,and D-dimer between the two groups after treatment,while there were no significant differences in other laboratory results after treatment;3.Chest CT score: Total chest CT score decreased in both groups before and after treatment,and the decrease degree was more obvious in the test group(P<0.05);4.Safety evaluation: During and after treatment,no liver or kidney damage and drug side effects were observed in the experimental group and the control group.5.Conclusion: "Huashiqing FEI method" can effectively improve the clinical symptoms of cough,sputum,sore throat and dry mouth in COVID-19 patients with mild and common type of dampness-heat lung syndrome,and is conducive to reducing chest CT score,with good safety.